The global smart inhalers market was estimated at $5.8 million in 2015 and is anticipated to hit $191 million by 2022, growing at a CAGR of 63.3% during the forecast period, according to the report published by Allied Market Research. The report has a title as “Smart Inhalers Market by Product [Inhalers (Dry Powder Inhalers, Metered Dose Inhalers) and Nebulizers], Indication (Asthma and COPD), End User (Patients and R&D) – Global Opportunity Analysis and Industry Forecast, 2014-2022.”
Global increase in air pollution, rise in population susceptible to indoor air pollutants, increasing prevalence of COPD and asthma, adherence to smart inhalers, mounting collaboration between pharmaceutical companies and smart inhaler manufacturers, and growing incidences of chronic conditions have fueled the growth of global smart inhalers market. On the other hand, COPD treatment and resistance towards adoption of smart inhalers have happened to curb the growth to some extent. Nevertheless, increased focus towards advanced treatment protocols, unmet needs in respiratory care and rising awareness about moderated healthcare costs have created multiple opportunities in the segment.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/1715
The report emphasizes on the various segments of global smart inhalers market. The market is categorized into product, indication, end-user and geography. Based on product, the market is divided into inhalers and nebulizers. The report splits the indication segment into asthma and COPD. Based on end-user, the market is fragmented into patients and R&D. By region, the market is analyzed across North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).
By product, Inhalers accounted for the largest market in 2015 and is projected to grow at a CAGR of 63.2%. Based on indication, COPD indication contributed to the largest segment and is anticipated to grow at a CAGR of 64.5%. This is due to significant increase in COPD incidence rate. By region, Europe and Asia-Pacific together accounted for around half of the market share in 2015 and are expected to dominate during the forecast period.
The key players in the smart inhalers market are encompassing the scope of their business operations in the developing countries by incorporating new products in their product portfolios. The report includes an analysis of the major market players such as Vectura Group plc., Boehringer Ingelheim GmbH, GlaxoSmithKline plc., Cohero Health, LLC; Propeller Health, OPKO Health, Inc. (Inspiro Medical Ltd.), Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), AstraZeneca plc, and Novartis AG. These market players have adopted a number of different strategies including expansion, mergers & acquisitions, partnerships, collaborations, and others to maintain their top status in the market.
For More Info Visit @ https://www.alliedmarketresearch.com/purchase-enquiry/1715
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060